G Medical Innovations Holdings Ltd. announced on May 25, 2023, Mr. Igor Bluvstein notified the company of his resignation as the chief financial officer of the company, effective on June 1, 2023. Mr. Bluvstein's resignation was not related to any disagreement with the company on any matter relating to its operations, policies or practices. On May 28, 2023, the board of directors of the company approved the appointment of Mr. David Seligman as the company's chief financial officer, effective on June 1, 2023 and approved the terms of his compensation.

Mr. Seligman has over twenty-seven (27) years of experience working as chief financial officer for various companies, including five public companies: LanOptics from 1996 to 1999; RadVision Ltd. from 1999 to 2003; NUR Macroprinters Ltd. from 2003 to 2005; Syneron Medical Ltd.; and Sonovia Ltd. from 2021 to 2022; as well as several private high tech companies. From 2019 through 2022, Mr. Seligman served as chief financial officer at Vocalis Health. From 2014 through 2018, Mr. Seligman served as the chief financial officer at YouAppi Inc. Among others, he took part in a successful IPO with RadVision Ltd. in March 2000 and in a successful turnaround recovery of NUR Macroprinters in 2003.

From 1993 to 1996, Mr. Seligman was senior financial analyst for Fidelity Investment in Boston, MA from 1993 to 1996. Mr. Seligman holds an MBA Degree in finance and management from Tel-Aviv University.